State Street’s Pyxis Oncology PYXS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $205K | Sell |
186,055
-746,143
| -80% | -$821K | ﹤0.01% | 3828 |
|
|
2025
Q1 | $913K | Sell |
932,198
-11,970
| -1% | -$11.7K | ﹤0.01% | 3449 |
|
|
2024
Q4 | $1.47M | Sell |
944,168
-7,083
| -0.7% | -$11K | ﹤0.01% | 3401 |
|
|
2024
Q3 | $3.49M | Buy |
951,251
+208,344
| +28% | +$765K | ﹤0.01% | 3114 |
|
|
2024
Q2 | $2.46M | Buy |
742,907
+633,552
| +579% | +$2.1M | ﹤0.01% | 3239 |
|
|
2024
Q1 | $466K | Buy |
109,355
+26,300
| +32% | +$112K | ﹤0.01% | 3666 |
|
|
2023
Q4 | $149K | Hold |
83,055
| – | – | ﹤0.01% | 3955 |
|
|
2023
Q3 | $165K | Buy |
83,055
+9,366
| +13% | +$18.6K | ﹤0.01% | 3987 |
|
|
2023
Q2 | $189K | Buy |
73,689
+11,400
| +18% | +$29.2K | ﹤0.01% | 4024 |
|
|
2023
Q1 | $250K | Hold |
62,289
| – | – | ﹤0.01% | 3984 |
|
|
2022
Q4 | $83.5K | Buy |
62,289
+31,300
| +101% | +$41.9K | ﹤0.01% | 4424 |
|
|
2022
Q3 | $61K | Hold |
30,989
| – | – | ﹤0.01% | 4614 |
|
|
2022
Q2 | $74K | Sell |
30,989
-113,806
| -79% | -$272K | ﹤0.01% | 4629 |
|
|
2022
Q1 | $585K | Buy |
144,795
+51,920
| +56% | +$210K | ﹤0.01% | 3977 |
|
|
2021
Q4 | $1.02M | Buy |
+92,875
| New | +$1.02M | ﹤0.01% | 3814 |
|